Joshua Fitch, Senior Editor

The fibrin sealant solution is now available in 18 countries.

"The novel RSV prevention strategies may reduce ICU morbidity and mortality for children," the study authors concluded.

Look back at several quick video interviews discussing the expanding role of artificial intelligence, how RSV treatment has evolved, and much more.

As the authors emphasized, “Expansion of these services will be essential to meet the needs of patients experiencing food allergy-related anxiety."

In all, 51.9% of patients entered with or achieved complete disease clearance at least once during the 48-week study.

The TrustTSC trial did not achieve its primary endpoint of percent reduction in 28-day frequency of TSC-associated seizures.

Paul Helmuth, MD, joined us to discuss potentially practical ways to implement AI in practice, as well as the importance of being transparent with families when using the evolving technology.

Interim analysis of the phase 3 REGAL Trial is anticipated in this quarter of 2024.

Brittany Bruggeman, MD, highlights the importance of newer, easier-to-use glucagon formulations in treating severe hypoglycemia in patients with type 1 diabetes.

Octavio Ramilo, MD, highlights key developments in the effort to prevent RSV disease in recent years, highlights vaccines and monoclonal antibodies.

This week, take a look at an approval for EDS, as well as highlights from IDWeek 2024, held in Los Angeles, California.

Melissa Fickey, MD, explains TMS therapy for major depressive disorder, and highlights key positive data for NeuroStar TMS Therapy, which was presented at the American Academy of Child and Adolescent Psychiatry (AACAP) meeting in Seattle, Washington.

Octavio Ramilo, MD, joins us to discuss new clesrovimab phase 2b/3 study data presented at IDWeek 2024 in Los Angeles, California.

There were no treatment or RSV-related deaths during the study.

"The magnitude of benefit, trajectory of symptomatic improvement, and dependency on the number of treatment sessions showed a treatment effect similar to that found in adults," stated study authors.

The approved indication is for patients aged 7 years and up with narcolepsy to treat cataplexy or excessive daytime sleepiness.

GLP-1 receptor agonists are increasingly being used to treat obesity in adolescents.

Investigators sought to test the efficacy of the Promoting Resilience in Stress Management (PRISM) intervention on levels of HbA1c.

The ongoing challenges of mental health, artificial intelligence, and the addressing of social determinants of health are key themes of pediatric health care are topics of discussion with Matthew Davis, MD, FAAP in this video interview.

Brittany Bruggeman, MD, emphasizes that many patients with type 1 diabetes are unaware of the availability of advanced technologies like CGMs and automated insulin delivery systems.

John Loiselle, MD, discusses careful pediatric exams, the growing use of ultrasound in emergency departments, and the rise of mental health cases affecting care.

Approval is based on a study in 116 adult and pediatric male patients with either severe hemophilia A or severe hemophilia B, both without inhibitors.

Brittany Bruggeman, MD, highlighted the ability to predict type 1 diabetes months to years in advance through islet autoantibodies, and how the pediatrician can play a role.

The FDA, CDC, and NIH have released a consensus statement regarding premature infant nutrition and necrotizing enterocolitis.

Contemporary Pediatrics' editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, talks RSV immunization and the availability of prevention tools.

This decision marks the second time the FDA has issued a complete response letter (CRL) for dasiglucagon to treat hypoglycemia in patients 7 days and up with congenital hyperinsulinism.

Steven Selbst, MD, discusses a recent trend in emergency medicine where non-operative management of appendicitis is being considered as an alternative to traditional surgery.

While rates of exclusive breastfeeding have slightly increased between 2016 and 2022, they remain under the Healthy People 2030 goal.

Angela Chun, MEd, MD, FAAP, discusses common causes of pediatric joint pain, serious red flags, and the importance of timely diagnosis of conditions like JIA and silent uveitis.

This week, take a look at several video interviews with experts from the 2024 AAP meetings, all in one place.